Chronic Kidney Disease Clinical Trials in Dallas, Texas

5 studies are recruiting for chronic kidney disease in Dallas, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

   This is a Phase III, randomized, double-blind, parallel-group, placebo-controlled multicenter study to investigate outcomes with elecoglipron compared with placebo in participants with CKD with and without T2DM who are on background SGLT2i (dapagliflozin) as GDMT and other SoC treatments for CKD.

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Research Site, Dallas, Texas

   Locations

   715 in total

   Run by

   AstraZeneca

   See if you can join NCT07753993 on ClinicalTrials.gov

2. Pivotal Study of the Velocity™ pAVF System

   This study will evaluate the Velocity Percutaneous Arteriovenous Fistula (pAVF) System, a new minimally invasive method for creating dialysis access. People with kidney failure often require dialysis, which depends on having a reliable arteriovenous fistula (AVF). Traditionally, AVFs are created wi…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   Advanced Dallas Hospital, Dallas, Texas

   Locations

   13 in total

   Run by

   Venova Medical

   See if you can join NCT07153939 on ClinicalTrials.gov

3. Sickle Cell Kidney Biorepository

   Kidney disease is a major cause of illness and death in people with sickle cell disease and sickle cell trait. Despite these concerning facts, we do not (1) have an in-depth understanding of how kidney disease starts in sickle cell disease and sickle cell trait, (2) have detailed insights into why …

   Stage

   Not phased

   Ages

   18 to 65

   Site

   Parkland Memorial Hospital, Dallas, Texas

   Locations

   2 in total

   Run by

   University of Texas Southwestern Medical Center

   See if you can join NCT07064174 on ClinicalTrials.gov

4. A Trial of Etelcalcetide in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

   This is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.

   Stage

   Phase 3

   Ages

   0 to 18

   Site

   Childrens Medical Center Dallas, Dallas, Texas

   Locations

   43 in total

   Run by

   Amgen

   See if you can join NCT03633708 on ClinicalTrials.gov

5. Behavioral AI to Predict and Increase Peritoneal Dialysis Uptake

   Scaled Insights Behavioral AI will be used to improve clinicians ability to detect and understand: The likelihood of patients with kidney failure opting for peritoneal dialysis and to select the right personalized nudge to get CKD patients to choose peritoneal dialysis Scaled Insights' can utilize …

   Stage

   Not phased

   Ages

   18 and older

   Site

   Dallas Renal Group, Dallas, Texas

   Run by

   Scaled Insights

   See if you can join NCT06533254 on ClinicalTrials.gov